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Edited by Barry HalliwellAbstract The proteasome is responsible for most intracellular
protein degradation and is essential for cell survival. Previous re-
search has shown that the proteasome can be inhibited by a num-
ber of oxidants, including 4-hydroxynonenal (HNE). The present
study demonstrates that HNE rapidly inhibits the chymotrypsin-
like activity of the 20S proteasome puriﬁed from liver. Subunits
containing HNE-adducts were identiﬁed following 2D gel elec-
trophoresis, Western immunoblotting, and analysis by MAL-
DI-TOF MS. At a time when only the chymotrypsin-like
activity was inhibited, the a6/C2 subunit was uniquely modiﬁed.
These results provide important molecular details regarding the
catalytic site-speciﬁc inhibition of proteasome by HNE.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The proteasome is a multi-subunit proteolytic complex that
is responsible for the regulated degradation of most intracellu-
lar proteins and is essential for cell survival [1]. The proteolytic
core of the proteasome, known as the 20S proteasome, appears
as a hollow cylinder of four stacked rings [2]. The two outer
rings, each composed of seven distinct a-subunits, serve to sta-
bilize the catalytic core and have been proposed as the site of
control for entry of substrates into the catalytic chamber [3].
The two inner rings are composed of seven distinct b-subunits.
In mammalian proteasome, three of the seven b-subunits con-
tain the active sites, which perform diﬀerent proteolytic cleav-
age. Based on mutational and crystal structural analysis, the
three catalytic activities, the peptidylglutamyl hydrolyzing,
trypsin-like, and chymotrypsin-like, have been assigned to
the b1, b2, and b5 subunits, respectively [4]. As a consequence
of an inﬂammatory stimulus, the constitutive catalytic subunits
b1, b2, and b5 can be replaced in nascent proteasomes by the
inducible subunits LMP2, MECL, and LMP7, respectively [5].
Because the proteasomeplays a central role in key cellular pro-
cesses, it is essential to understand themechanistic basis for pro-
teasome inhibition. Previous research has shown that the
proteasome can be inhibited by a number of oxidants, including
4-hydroxynonenal (HNE) [6]. HNE is an aldehyde that origi-*Corresponding author. Fax: +1 612 626 0781.
E-mail address: ferri013@umn.edu (D.A. Ferrington).
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forms a mixture of adduct types on the side-chains of cysteine,
lysine, and histidine through a Michael-type nucleophilic addi-
tion [7]. The addition of HNE adducts on both membrane and
soluble proteins has been shown to inhibit protein function [8–
11]. Further, direct attachment of HNE to the proteasome has
been ascribed to the decline in proteasome activity in studies
of cardiac muscle following ischemia reperfusion [12], with cere-
bral ischemia [13], in kidney homogenates following incubation
with HNE [14], and in lymphocytes and spinal cord from aged
organisms [15,16]. However, the molecular details responsible
for the loss in activity have not been elucidated.2. Materials and methods
2.1. Materials
Proteasome substrates were purchased from Sigma and Calbiochem.
HNE was from Cayman Chemical. Antibodies and their respective
companies are as follows: Proteasomal subunits (Aﬃnity Bioreagents),
HNE (Alpha Diagnostics and Calbiochem), heat shock protein 90
(HSP90) (StressGen), alkaline phosphatase-conjugated goat anti-
rabbit or -mouse secondary antibody (BioRad). All reagents for sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) and
Western immunoblotting were supplied by BioRad. Immobline dry
strips (pH 3–11, non-linear, 11 cm) were from Amersham Pharmacia
Biotech. Immobilon-P polyvinylidene diﬂuoride membrane (PVDF)
and C18 ZipTips were from Millipore. The bicinchoninic acid (BCA)
protein assay kit was obtained from Pierce. HPLC-grade dimethyl sulf-
oxide and all reagents for the preparation of samples for mass spec-
trometry were from Aldrich.
2.2. Preparation and characterization of liver 20S proteasome
The 20S proteasome was puriﬁed from frozen rat liver as described
[17]. Proteasome was suspended in 50 mM potassium phosphate (pH
7.0) and 0.1 M KCl and aliquots were stored at 80 C. Protein con-
centrations were determined using the BCA protein assay and bovine
serum albumin as the standard protein. The relative content of
LMP7 and b5 subunits was determined by Western immunoblotting
(see Section 2.6) comparing the immune reaction of subunit-speciﬁc
antibodies in the liver 20S with the reaction in protein from retinal pig-
ment epithelial cells containing a known percent of each subunit. In
these cells, no LMP7 is present in the absence of cytokines. Induction
of the immunoproteasome was accomplished by incubating the cells
with 100 U/ml interferon-c for 72 h. Mixtures of cytokine-free and
cytokine-exposed cells were used to generate a standard curve of
known percentages of the inducible and constitutive subunits.
2.3. Incubation of proteasome with HNE
20Sproteasomewas incubatedwith 20lMHNEat various times from
0 to 240min. Themolar ratio of the 20S proteasome (mass700 kDa) to
HNE (mass 156 Da) was approximately 1:10000. Preliminary experi-
ments showed that 20 lM was the optimal concentration to achieve
maximal inhibition without the formation of HNE-protein aggregates,ation of European Biochemical Societies.
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was quenched by either (1) addition of 10-fold excess buﬀer to measure
activity, (2) addition of reducing buﬀer and immediate 1D electrophore-
sis of protein, or (3) dialysis of the proteasome in 20 mM Tris (pH 7.4)
overnight at 4 C to prepare prior to 2D electrophoresis.Fig. 1. Time-dependent modiﬁcation of the 20S proteasome by HNE.
(A) Silver-stained gel of proteasomal subunits resolved by 13% SDS–
PAGE following incubation with HNE for varying times. Arrow
indicates the position of HSP90, determined by a positive immune
reaction with anti-HSP90. (B) Western immunoblot probing for HNE
adducts on proteins from the 20S proteasome following incubation
with HNE for varying times. Protein loads were 1 lg per lane.
Molecular mass standards are (in kDa): 97.4, phosphorylase b; 66.2,
bovine serum albumin; 45, ovalbumin; 31, carbonic anhydrase; 21.5,
soybean trypsin inhibitor; and 14.4, lysozyme.2.4. Measurement of proteasome activity
The ﬂuorogenic peptides LLVY-AMC (150 lM), LSTR-AMC (200
lM), and LLE-AMC (200 M) were used to measure the chymotrypsin-
like, trypsin-like and peptidylglutamyl hydrolyzing activities of the
proteasome, respectively. Proteasome (0.3 lg) was pre-incubated with
either buﬀer (control) or HNE for a speciﬁc length of time at room
temperature. Proteasome activity was measured as described previ-
ously [18]. Measurement of proteasome inhibition by HNE was mea-
sured on three separate preparations of 20S proteasome. The kinetics
of HNE-inhibition was determined from ﬁtting a curve assuming
ﬁrst-order exponential decay to the experimental data, plotted as rela-
tive activity versus time of HNE incubation (Origin version 6.0).
2.5. Gel electrophoresis
1D SDS–PAGE separation of proteasomal subunits (1 lg) was
accomplished using a 12% resolving gel with a 3% stacking gel [19].
For 2D electrophoresis, proteasomal subunits were ﬁrst focused across
a non-linear pH gradient of 3–10 (11 cm) using a Protean IEF Cell
(BioRad). Puriﬁed 20S (15 g) was diluted in sample buﬀer (8 M urea
and 4% CHAPS) and focused for 50000 V h over 23 h. Second dimen-
sion was performed using 12% SDS–PAGE [19]. Two gels were run in
parallel. One gel was silver stained using the Silver Stain Plus Kit. The
alternate gels were used for Western immunoblotting. Images were
captured using a Fluor-S MultiImaging system (BioRad).
2.6. Western immunoblotting of 1D and 2D gels
Proteins were electrophoretically transferred to PVDF membrane
and probed with either the monoclonal antibody to HSP90, or poly-
clonal antibodies that recognize proteasomal subunits (b1, b2, b5,
LMP2, LMP7, a6/C2, a-subunits, and b-subunits), amino acid-HNE
Michael adducts or the reduced forms of HNE (1:1 amino acid–HNE
Michael adducts). The speciﬁcity of the HNE antibody recognizing
1:1 amino acid:HNE Michael adducts has been thoroughly character-
ized [20]. Prior to application of the antibody that recognizes the re-
duced forms of HNE, blotted proteins were reduced by incubating
the PVDFmembranes in a solution containing 25 mM sodium borohy-
dride in 100 mMMOPS (pH 8.0) for 10 min at room temperature. So-
dium borohydride reduces the carbonyl present on Michael adducts
[21]. For the HNE antibodies, Immun-blot Ampliﬁed Alkaline Phos-
phatase Kit (1:3000 each of biotinylated goat anti-rabbit IgG, strepta-
vidin, and biotinylated alkaline phosphatase) was used in conjunction
with the substrate BCIP-NBT to visualize the immunoreaction. For
all other antibodies, the secondary antibody was either goat anti-mouse
or -rabbit alkaline phosphatase without the ampliﬁcation system.
Images were captured using a Fluor-S MultiImaging System (BioRad).
2.7. Selection and preparation of proteins for mass spectrometry
Western immunoblotting of 2D gels was used to identify speciﬁc
protein spots containing HNE adducts. Immune reactive spots were
aligned with spots on silver stained gels. The selected spots were ex-
cised and proteins digested in-gel overnight at 37 C with trypsin. Pep-
tides were extracted as described [22].
2.8. Matrix-assisted laser desorption ionization-time of ﬂight mass
spectrometry
The peptide mixture was desalted using Millipore C18 ZipTips fol-
lowing the manufacturers protocol. Data were acquired on a QSTAR
XL quadrupole-TOF mass spectrometer (ABI) as described [22]. Mea-
sured peptide masses were used to search the NCBI and Swiss-Prot se-
quence databases for protein identiﬁcations and database accession
numbers using Mascot (www.matrixscience.com) or BioAnalyst
(ABI) software. All searches were performed with a mass tolerance
at 50 ppm. Positive identiﬁcation required a minimum of three peptide
matches and a probability score that indicates high concordance be-
tween the masses of experimentally derived peptides with theoretical
masses of peptides from the matched protein, and a positive identiﬁca-
tion from at least one product ion spectrum.2.9. MS/MS sequencing of peptides
Product ion spectra were collected in an information dependent
acquisition mode using the enhanced feature of the scan mode with
a three second scan time. Experimental fragment masses were used
to search the NCBI and Swiss-Prot sequence databases for protein
identiﬁcations and database accession numbers using Mascot
(www.matrixscience.com) or BioAnalyst (ABI) software. Peptides with
a minimum of four consecutive b and y ions were considered as an
acceptable match.3. Results
3.1. Selective Inhibition of the 20S proteasome by HNE
To directly test the eﬀect of HNE modiﬁcation on protea-
some function, the 20S proteasome puriﬁed from liver was
incubated with HNE from 0 to 240 min. Fig. 1 shows a sil-
ver-stained polyacrylamide gel and the corresponding Western
immunoblot probed for HNE-adducts. Prior to incubation
with HNE, there is a prominent reaction in a single protein
band at 26 kDa before exposure to exogenous HNE (Fig.
1B). Following incubation, there is a time-dependent increase
in the reaction in a protein band at 33 kDa and in proteins
with migrations at higher molecular masses. By four hours
of incubation, HNE-adducts are present in the proteins at
the interface between the resolving and stacking gels and near
the top of the resolving gel, suggesting the formation of protein
aggregates cross-linked by HNE.
In a parallel experiment, the activity of each catalytic site
was measured using the ﬂuorogenic peptides LLE-AMC,
LSTR-AMC, and LLVY-AMC, to assay the peptidylglutamyl
hydrolyzing, trypsin-like, and chymotrypsin-like activities,
respectively. We observed a time-dependent inhibition of each
catalytic site that diﬀered in both the extent and the rate of
inhibition (Fig. 2). The peptidylglutamyl hydrolyzing activity
was the least sensitive to HNE; only 25% inhibition was ob-
served during 4 h of incubation. The trypsin- and chymotryp-
sin-like activities were both inhibited by 45%. However,
rapid inactivation of the chymotrypsin-like activity occurred
within 2 min of incubation with HNE, whereas maximal inhi-
bition of the trypsin-like activity occurred in 158 min. These
Fig. 3. Two-dimensional gel resolution of proteasomal subunits before
and after incubation with HNE. The 20S proteasome puriﬁed from
liver was incubated in the absence of HNE (control) (A,B) or presence
of 20 M HNE for 15 min (C,D). Proteasome (15 lg) was then resolved
by 2D gel electrophoresis. One gel was stained with silver and used for
mass spectrometric identiﬁcation of proteins (A,C). Gel A shows the
proteins corresponding to the catalytic b-subunits (1, b1i/LMP2; 2, b1/
Y; 3, b2/Z; 4, b5/X; and 5, b5i/LMP7), as determined by Western
immunoblotting using protein-speciﬁc antibodies. The second gel of
each pair was used for Western immunoblotting to locate subunits
containing HNE-adducts (B,D). Arrows on Western blots indicate
HNE reactions unique to that incubation time. Open arrows are
modiﬁed subunits with more acidic migration than parent protein. All
numbered spots were identiﬁed by MALDI-TOF MS and data base
search (Table 1). The indicated pI values (top of A,B) were determined
from an experimental calibration curve supplied by Amersham
Biosciences. Molecular mass standards are (in kDa): 45, ovalbumin;
31, carbonic anhydrase; and 21.5, soybean trypsin inhibitor.














Fig. 2. Time-dependent inactivation of the proteasome by HNE. The
peptidylglutamyl hydrolyzing (triangle), chymotrypsin-like (square)
and trypsin-like (circle) activities were determined by measuring the
proteolysis of the ﬂuorogenic peptides LLE-AMC, LLVY-AMC and
LSTR-AMC, respectively. Data are reported as means (±SEM) for
duplicate measurements from three separate preparations of puriﬁed
20S proteasome. Initial rates of peptide proteolysis in the absence of
HNE were 17.2 ± 6.8 (LLVY), 1.1 ± 0.2 (LSTR), and 3.2 ± 1.2 (LLE)
nmol/mg/min.
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sensitive to HNE modiﬁcation, although prolonged exposure
to HNE also aﬀects the activity of the other catalytic sites.
3.2. Identiﬁcation of subunits containing HNE-adducts
To investigate the mechanistic basis for the rapid inhibition
of the chymotrypsin-like activity by HNE, we identiﬁed sub-
units that were modiﬁed by HNE using a combination of
2D-PAGE, Western immunoblotting, and mass spectrometry.
After localizing the HNE-immune reaction to speciﬁc protein
spots, the corresponding subunits were identiﬁed by perform-
ing in-gel trypsin digests and peptide mapping using full scan
matrix-assisted laser desorption ionization-time of ﬂight mass
spectrometry (MALDI-TOF MS). Tandem MS data were ac-
quired to provide unambiguous conﬁrmation of a subunits
identity. To identify the HNE-modiﬁcations that were re-
stricted solely to a loss in chymotrypsin-like activity, we chose
an incubation time of 15 min. During this short incubation, a
strong immune reaction of a single protein band (Fig. 1) cor-
relates with maximal inhibition of chymotrypsin-like activity
and no eﬀect on the other activities (Fig. 2).
Following 2D gel resolution of subunits from the 20S cata-
lytic core, we observed a larger number of protein spots than
predicted for the 17 catalytic core subunits known from the
mammalian proteasome (Fig. 3). Our analysis of individual
protein spots by either MS or Western immunoblotting
showed that many of the individual subunits were found in
multiple spots or smears migrating at the same molecular mass
but at diﬀerent isoelectric points (pI). These isoelectric variants
from individual proteins are known as ‘‘charge trains’’ and re-
sult from post-translational modiﬁcations that alter the intrin-
sic charge of the protein. Post-translational modiﬁcations
described for individual subunits that alter the proteins pI in-
clude phosphorylation, acetylation, and glycosylation [23–25].
HNE-modiﬁcation of the e-amino group of lysine would also
cause the modiﬁed protein to migrate to a more acidic position
than the unmodiﬁed parent protein. Several protein spots on
the silver stained gel demonstrated very light negative staining.This type of ‘‘reversed’’ staining with silver is normally associ-
ated with proteins containing sugar moieties [26].
As a reference point, we localized the position of the b-
subunits containing the catalytic sites by Western immunoblot
using subunit-speciﬁc antibodies. The protein spots corre-
sponding to each catalytic subunit are indicated on the sil-
ver-stained gel from the control (no HNE) sample (Fig. 3A).
A positive immune reaction for both the constitutive (b1/Y,
b2/Z, and b5/X) catalytic subunits and their inducible counter-
parts (b1i/LMP2 and b5i/LMP7) was evident in the 20S from
liver. (We were unable to obtain an unambiguous immune
reaction for b2i/MECL.) The apparent molecular mass and
pI values were consistent with the theoretical values for sub-
units without their corresponding propeptide (Table 1). To
estimate the percent composition of the inducible (LMP7)
and constitutive (b5) subunits responsible for the chymotryp-
sin-like activity, we compared the immune reaction in the liver
20S with the reaction in cells containing a known percentage of
each subunit (data not shown). We estimated that our 20S
preparation contained 70% LMP7 and 30% b5.
In the control sample, Western immunoblot analysis with
anti-HNE showed a strong immune reaction in ﬁve distinct
proteins spots migrating between pI 5.8 and 7.0 and at a mass
of 26 kDa (Fig. 3B). MS analysis determined that these pro-
tein spots were the isoelectric variants of the a2/C3 subunit. A
light immune reaction was also observed in multiple spots
migrating more acidic to the a2/C3 subunit at a mass of 28
kDa. These proteins were identiﬁed as the a4/C6 subunit.
The pattern of migration for these subunits and the HNE-
modiﬁed subunits identiﬁed following 15 min of incubation
(see below) was consistent with the theoretical values for their
respective molecular mass and pI values for the unmodiﬁed
protein plus isoelectric variants containing post-translational
modiﬁcations that alter the intrinsic charge (Table 1).
Table 1
Subunit identiﬁcation of 20S proteasome
Spota no. 20S subunitb Accession No. Molecular mass pI Identiﬁcation
Exp.c Theo.d Exp.e Theo. WBf MALDI-TOF MS
kDa Da
% Coverage # Peptides
1 b1i/LMP2 P28077 23 21354 4.7 4.77 X
2 b1/Y P28073 23 21964 4.8 4.98 X
3 b2/Z Q9JHW0 27 25314 5.7 5.84 X
4 b5/X P28075 26 22482 8.0 8.33 X
5 b5i/LMP7 P28064 26 22733 8.8 8.57 X
6 a4/C6 XP_342599.1 30 28439 7.9 8.60 20 3
6 0 a4/C6 30 28439 7.3 8.60 27 7
7 a2/C3 P17220 27 25795 6.8 7.12 38 7
7 0 a2/C3 27 25795 6.3 7.12 46 7
700 a2/C3 27 25795 5.9 7.12 35 6
8 a6/C2 P18420 33 29517 6.2 6.14 44 12
8 0 a6/C2 33 29517 6.0 6.14 30 6
a Protein spots were excised from 2D gels shown in Fig. 3 and analyzed on a QSTAR XL quadrupole MALDI-TOF MS instrument.
b First subunit name follows nomenclature by Groll [2].
c Exp., experimental molecular mass values were estimated using the experimental calibration curve generated from the Rf of low molecular weight
silver stained markers.
d Theo., theoretical molecular mass and pI values were calculated from the Swiss-Prot sequences without the propeptide sequences.
e Exp., experimental pI values were estimated using the calibration curve supplied for 11 cm, pH 3–11, non-linear IPG strips (Amersham Bio-
sciences).
f WB, Western immunoblotting.
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noblot analysis probing for HNE-adducts showed a promi-
nent, new reaction of multiple spots between pI 5.8 and 6.2
and at a mass of 33 kDa (Fig. 3D). These proteins were iden-
tiﬁed by MS analysis as the a6/C2 subunit (Fig. 4). Fig. 4A
shows a MALDI-TOF mass spectrum of peptides generated
by in-gel trypsin digestion from spot 8 0. Six peptides covering
30% of the primary sequence for the a6/C2 subunit were iden-
tiﬁed from the peptide mass ﬁngerprint. The fragmentation of
peptide 1431 generated by tandem MS produced a spectrum
containing 9 of 12 b ions and 8 of 12 y ions matching residues
19-30 of the a6/C2 subunit (Fig. 4B). Six b- and y-series ions of
low intensity (m/z ranging between 129 and 605, not indicated
on spectrum) with the loss of a water or ammonia also
matched. Fragmentation of one additional peptide of a singly
charged ion of 1779 matched the sequence for residues 4–18 of
the a6/C2 subunit (data not shown). These data provide unam-
biguous identiﬁcation of the a6/C2 subunit.
One additional change in immune reaction and protein
staining occurred with the a2/C3 subunit. After the 15 minute
incubation, two new immunoreactive protein spots appeared
to the acidic side of spots 7 and 7 0, which had been identiﬁed
as a2/C3. On silver stained gels, these new protein spots were
approximately equivalent to the parent spots 7 and 7 0. The
acidic migration of new protein spots suggests the addition
of HNE-adducts on one or more lysine residues.
3.3. Conﬁrmation of antibody speciﬁcity
A second antibody that recognizes the reduced form of ami-
no acid:HNEMichael adducts was used to verify the speciﬁcity
of the antibody used in the previous experiments. As shown in
Fig. 5, identical immune reactive bands were observed for 20S
incubated with HNE for 15 min (Lanes 2 and 3). The absence
of reaction for HNE modiﬁed BSA that was not reduced with
sodium borohydride prior to exposure to the antibody that
recognizes the reduced HNE Michael adducts (Lane 5) also
conﬁrms the speciﬁcity of this second antibody. Taken to-gether, the immune reaction of two antibodies that recognize
diﬀerent chemical forms of HNE provides convincing evidence
for the presence of HNE Michael adducts on proteasomal
subunits.4. Discussion
The goal of this study was to test the eﬀect of HNE on indi-
vidual catalytic activities and elucidate the molecular details
responsible for HNE-induced inhibition by identifying the sub-
units containing HNE-adducts. Activity measurements per-
formed during incubation with HNE showed rapid inhibition
of the chymotrypsin-like activity, followed by slower inhibition
of the other catalytic sites. Resolution of modiﬁed subunits by
2D gel electrophoresis and Western immunoblotting revealed
that the a6/C2 subunit is uniquely modiﬁed at a time when
only the chymotrypsin-like activity is inhibited. These results
provide important molecular details regarding the catalytic
site-speciﬁc inhibition of the proteasome by HNE. Under-
standing how the 20S proteasome reacts in the presence of ele-
vated levels of HNE is particularly relevant, since the 20S
proteasome has been suggested as the primary mechanism
for degrading damaged proteins following an oxidative insult
[27,28]. As a caveat, the identity of the proteasome species that
is functionally active under diﬀerent physiological conditions
remains controversial.
Inhibition of the chymotrypsin-like activity induced by HNE
would have a direct negative impact on many key cell func-
tions regulated by the proteasome, since it is primarily the chy-
motrypsin-like activity that determines the rate of protein
breakdown [4,29,30]. The exquisite sensitivity of the chymo-
trypsin-like site to modiﬁcation by HNE was also demon-
strated in two diﬀerent neuronal cell lines following
incubation with HNE [31]. In these studies, the loss in activity
occurred along with the appearance of proteasome HNE-
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Fig. 4. Mass spectrometric analysis of tryptic peptides from the 20S
proteasome subunit a6/C2. (A) Full scan of a MALDI-TOF MS
peptide mass ﬁngerprint from spot 8 0 (Fig. 3D). The spectrum shows
six peptides that matched the theoretical m/z values for residues in the
sequence from rat 20S proteasome subunit a6/C2. The six matching
peptides covered 30% of the sequence (Table 1). * denotes products of
trypsin autolysis. (B) Product ion spectrum for fragmentation of the
singly charged ion 1431 of the IHQIEYAMEAVK peptide formed by
MALDI ionization. The amino acid sequence is displayed above the
spectrum and corresponds to residues 19–30 of proteasome subunit a6/
C2. The y- and b-ions found experimentally are written above and
below the sequence, respectively, and are indicated above the corre-
sponding peak in the spectrum. Immonium ions are denoted as (I) on
spectrum. Fragment ion nomenclature was established by Biemann
[50]. The data were plotted as a function of m/z values after raw mass
spectral data were smoothed, centroided, and labeled in BioAnalyst
(ABI).
Fig. 5. Comparison of immune reactions between antibodies that
recognize diﬀerent chemical forms of HNE-Michael adducts. Proteins
were resolved by 13% SDS–PAGE, then blotted on a PVDF
membrane. The lane containing the 20S proteasome was cut in half
so that the reaction with the two antibodies could be aligned. Reaction
of the antibody that recognizes amino acid:HNEMichael adducts with
HNE-modiﬁed bovine serum albumin (Lane 1) and 20S proteasome
incubated with HNE for 15 min (Lane 2, arrow). Reaction of the
antibody that recognizes the reduced form of amino acid:HNE
Michael adducts with 20S proteasome incubated with HNE for 15
min (Lane 3, right half of blot) and HNE-modiﬁed bovine serum
albumin (Lane 4). Both samples were reduced with sodium borohy-
dride prior to exposure to the antibody. Reaction of the antibody
recognizing the reduced form of HNE with HNE-modiﬁed bovine
serum albumin without prior reduction with sodium borohydride
(Lane 5). Protein loads were 1 lg. Lane M is the molecular mass
marker; corresponding masses are shown on the right.
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showing the partial reversal of peroxide-induced inhibition of
chymotrypsin-like activity by DTT and the inhibition of chy-
motrypsin-like activity by sulfhydryl compounds, such as N-
ethyl-maleimide [32,33], suggest that at least one of the sites
critical for maintenance of chymotrypsin-like activity is a cys-
teine residue. In support of this idea, other studies have sug-
gested that the reversible S-glutathionylation of cysteine may
be an important physiological regulator of proteasome chymo-
trypsin-like activity [33,34]. Taken together, these results indi-
cate that the intracellular redox state may be closely linked to
proteasome-mediated proteolysis. Further, HNE modiﬁcation
of a key cysteine is a potential means for rapid inactivation of
the chymotrypsin-like activity.In the present study, the trypsin-like activity was inhibited to
the same extent as the chymotrypsin-like activity, but at a
much slower rate. This observation suggests several possibili-
ties, including diﬀerential susceptibility to HNE-modiﬁcation
or partial protection of sites critical for the trypsin-like activ-
ity. The contaminant, HSP90, which co-puriﬁed with the 20S
(Fig. 1, arrow), could be the putative protector against
HNE-inhibition. In previous studies, exogenous addition of
HSP90 to puriﬁed 20S proteasome and overexpression of
HSP90 in cells protected the trypsin-like activity from inhibi-
tion by both HNE and metal-catalyzed oxidation [21,35,36].
In our study, HSP90 is not modiﬁed by HNE during the incu-
bation (Fig. 1). Therefore, the mechanism of protection does
not include providing a non-proteasome target for HNE mol-
ecules, i.e., HSP90 is acting as a ‘‘molecular sponge’’. Rather,
it is likely that the binding site of HSP90 shields residues that
are sensitive to modiﬁcation by HNE.
The plot of the time-dependent inhibition of the three cata-
lytic activities (Fig. 2) shows that the maximal extent of inhibi-
tion is less than 50%. These results suggest that only half of the
proteasome population were inhibited even in the presence of
HNE in molar excess. One explanation is that at least a por-
tion of the population was in a conformation that makes it less
susceptible to HNE modiﬁcation and subsequent inactivation.
Additionally, both the composition of the b-subunits (constitu-
tive or inducible) and ‘‘activation state’’ (active or latent) of
the puriﬁed 20S proteasome have been shown to alter the cat-
alytic activity in response to oxidants or following binding of
proteins, such as HSP90 [35–38]. For example, Amici et al.
[38] showed that proteasomes isolated from thymus, composed
mainly of the inducible subunits, were more sensitive to perox-
ynitrite inactivation. In contrast, proteasomes isolated from
brain, composed mainly of the constitutive subunits, were
resistant to peroxynitrite inactivation. Liver 20S proteasome
contains both constitutive and inducible b-subunits, as
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tein-speciﬁc antibodies (Fig. 3A) and also reported by others
[39–41]. In our preparations, approximately 70% of the chy-
motryptic subunit is LMP7. In view of the evidence demon-
strating increased susceptibility of proteasome containing the
inducible subunits to oxidative damage, the 50% maximal inhi-
bition achieved in the current study could reﬂect the diﬀeren-
tial susceptibility of the immunoproteasome versus the
constitutive proteasome.
A logical prediction of the mechanism of inactivation by
HNE would be the direct modiﬁcation of the b-subunits at
either key residues required for activity or at sites that would
disrupt speciﬁc interactions between adjacent b-subunits. While
we did not detect HNE-adducts on b-subunits, it is possible that
our method of analysis did not have the required sensitivity to
reveal modiﬁcation of a limited number of HNE-adducts. Addi-
tionally, the HNE could have assumed a form, i.e., ﬂuorescent
cross links, that is not recognized by the antibodies used in this
study. However, we did observe a robust immune response for
modiﬁcation of a-subunits during the HNE-induced inhibition
of the proteasome. These results are consistent with a report of
HNE modiﬁcation of only a-subunits for 20S proteasome iso-
lated from heart muscle following an oxidative stress induced
by ischemia/reperfusion [12]. Examination of the crystal struc-
ture of mammalian 20S proteasome provides potential mecha-
nistic explanations for our results based on the physical
arrangement of the a-subunits and the catalytic subunits
[42,43]. The a6/C2 subunit is an adjacent neighbor to the b5 sub-
unit that contains the chymotrypsin-like active site. Although
the details of how cross-talk occurs between these two subunits
are still unclear, the interaction of the a6/C2 subunit with either
micro- or macromolecular ligands has a profound eﬀect on the
chymotrypsin-like activity. For example, direct binding of lipo-
polysaccharide to the a6/C2 subunits in proteasome isolated
from macrophages or rabbit muscle selectively activated the
chymotrypsin-like activity [44]. The a6/C2 subunit is also the
putative binding site for the regulatory protein, PA28 [45].
Binding of this macromolecular ligand of the 20S signiﬁcantly
increases the hydrolysis of ﬂuorogenic peptides, especially the
peptides hydrolyzed by the chymotrypsin-like site [46].
Prior to incubation with exogenously added HNE, the a2/C3
and a4/C6 contained HNE-adducts. While we cannot rule out
that the modiﬁcation occurred during the puriﬁcation process,
the consistent presence of HNE-adducts on these subunits in
three separate liver preparations and in 20S puriﬁed from skel-
etal muscle (unpublished observation) provides strong evidence
for their modiﬁcation in vivo. Further, the positive immune
reaction with a second antibody that recognizes the reduced
form of amino acid:HNE Michael adducts veriﬁes the selective
recognition of two diﬀerent chemical forms of HNE. These re-
sults also imply that HNE-modiﬁcation is not a random pro-
cess and that even in a multi-subunit complex such as the
proteasome, speciﬁc proteins are molecular targets for HNE.
Proteasome function is intimately linked to its subunit com-
position and structural properties, such as post-translational
modiﬁcations. An important observation that has recently
emerged is the plasticity of the proteasome subunit composi-
tion in response to changing cellular environments. In cultured
neuronal cells, both low (sublethal) levels of oxidative stress
and cellular expression of aggregate-prone proteins resulted
in increased expression of the inducible subunit, LMP2
[47,48]. Increased content of the inducible subunits, LMP2and LMP7, was also reported in aged muscle [18]. While the
consequences of altering the subunit composition are not fully
understood, it may be a compensatory change that primes the
proteolytic machinery to accommodate an increased demand
for degradation of speciﬁc substrates, i.e., oxidized proteins.
These changes could confer protection against subsequent
stresses applied to the cell.
Results from this study provide insight into how modiﬁca-
tion of a speciﬁc proteasomal subunit by HNE can aﬀect the
activity of a select catalytic site. These results also provide a
potential explanation for the selective loss of chymotrypsin-
like activity we have previously reported in retinal proteasome
from aged rats [49]. However, we also acknowledge that in the
cellular context, proteasomal inhibition by HNE-conjugated
proteins may also play a signiﬁcant role in inhibiting protea-
some function. Knowledge of the structural modiﬁcations that
aﬀect proteasome activity, such as altering the subunit compo-
sition or oxidative modiﬁcation, is critical to understanding its
function under both normal and pathological conditions.
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